+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      The Ontogeny of Gonadotropin-Releasing Hormone Neurons in the Chick



      S. Karger AG

      Chick, GnRH, Olfactory epithelium

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The origin of gonadotropin-releasing hormone (GnRH) neurons in the olfactory placode and their subsequent migration into the central nervous system (CNS) has been described in several species. The current study was undertaken to delineate the time course and route of GnRH neuronal migration in the chick using antisera generated against both the mammalian form of GnRH (LR1) and a specific chicken GnRH (cGnRH I). Chicks aged E4.5 through day of hatching were processed for GnRH immunocytochemistry. Under the incubation conditions employed in this study, GnRH neurons first appeared on E4.5 in the olfactory epithelium. GnRH neurons exit from the olfactory epithelium and follow the extracranial course of the olfactory nerve to the anterior pole of the developing forebrain. Within the nerve, cells are in close apposition to each other. By E5, cells had reached the surface of the telencephalon. Upon entering the CNS, the GnRH neurons dispersed within the neuropil and continued their migration as individuals. As development progressed, GnRH neurons migrated dorsally and caudally within the brain and reached their adult positions by E12. GnRH axons were detected in the vicinity of GnRH cell bodies with the cGnRH I antiserum as early as E4.5; however, GnRH axons did not reach the median eminence until E14. These results extend earlier reports in mammal and chick on the extracranial origin of GnRH neurons and their path of entry into and dispersion within the CNS.

          Related collections

          Author and article information

          S. Karger AG
          08 April 2008
          : 58
          : 6
          : 597-608
          Department of Anatomy and Cell Biology, Columbia University, New York, N.Y., USA
          126598 Neuroendocrinology 1993;58:597–608
          © 1993 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 12


          Comment on this article